Oridonin Delays Aging Through the AKT Signaling Pathway

Aging is a major risk factor for chronic diseases and disability in humans. Nowadays, no effective anti-aging treatment is available clinically. In this study, oridonin was selected based on the drug screening strategy similar to Connectivity MAP (CMAP) but upon transcriptomes of 102 traditional Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yongpan, Zhu, Jie, Wang, Xin, Sun, Xinpei, Luo, Chunxiong, Zhang, Yukun, Ye, Yuwei, Li, Xiaowei, Abulizi, Abudumijiti, Huang, Zhizhen, Zhang, Hang, Yang, Baoxue, Xie, Zhengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157590/
https://www.ncbi.nlm.nih.gov/pubmed/35662728
http://dx.doi.org/10.3389/fphar.2022.888247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157590/
https://www.ncbi.nlm.nih.gov/pubmed/35662728
http://dx.doi.org/10.3389/fphar.2022.888247

Ejemplares similares